ACRS
Aclaris Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.04 / 10
Outperform
Sentiment scores 7.04/10 (Outperform) with a 7.6 fund‑flow rating. All size categories show positive inflows (~0.51 ratio). Analyst coverage is limited but unanimous: one Strong Buy (100%). Combined bullish sentiment and strong money inflows support a positive near‑term bias.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-19
InstitutionHC Wainwright & Co.
Times predicted6
Historical Win Rate33.3%
What is the market sentiment for ACRS?
- ACRS holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.04/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
